MedPath

Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer

Not Applicable
Conditions
on-small cell lung cancer
Registration Number
JPRN-UMIN000016086
Lead Sponsor
Division of Chest Surgery, Toho University Omori Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1)Interstitial pneumonia 2)Pleural effusion, ascites, cardiac effusion 3)Active double malignancies 4)Serious medical complications 5)Diarrhea 6)Pregnancy, breastfeeding or suspected of being pregnant 7)Male with intent of reproduction 8)Drug allergy 9)Allergy to ingredients of S-1 10)Administering fluorinated pyrimidine other than S-1 11)Administering flucytosine 12)Others judged by attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath